에서 실시간으로 운영 중이에요! 자세히 알아보기

Becton Dickinson

BDX

시가총액 US$522억

191.75 USD

-2.01

1.04%

장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT

프리마켓

시간외 거래

191.75

0.00

0%

1일

-1.04%

5일

4.03%

1개월

5.44%

3개월

19.9%

6개월

23.85%

연초 이후

-1.64%

1년

3.5%

5년

-17.57%

10년

14.57%

소개: Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

직원 수: 72,000

건강관리 의료 장비 및 용품

뉴스

긍정적

중립

부정적

투자 심리 3개월

긍정적 45.1%

중립 52.9%

부정적 2%

Zacks Investment Research

BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients

BDX's Revello stent shows strong nine-month AGILITY trial results, with high vessel patency and low failure rates, boosting its peripheral vascular prospects.

BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients

24/7 Wall Street

3 Overlooked Healthcare Dividend Stocks That Could Keep Paying for Decades

Most income investors chase flashy yields and overlook the quiet compounders that have raised their dividends through recessions, rate shocks, and global pandemics.

3 Overlooked Healthcare Dividend Stocks That Could Keep Paying for Decades

Zacks Investment Research

Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?

BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026

FRANKLIN LAKES, N.J., Oct. 8, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m.

BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026

BD and Global Health Leaders Call for Accelerated Maternal Life Saving Measures Worldwide

Physicians, policymakers, and global health experts urge broader access to monitoring technologies that can help identify life-threatening complications earlier, helping more mothers survive childbirth and giving babies a healthier start in life. FRANKLIN LAKES, N.J.

BD and Global Health Leaders Call for Accelerated Maternal Life Saving Measures Worldwide

Zacks Investment Research

BDX Expands U.S. Manufacturing With $19B Healthcare Investment

BD plans a $19B U.S. investment, including $3B for manufacturing, to boost domestic medical consumables capacity and supply-chain resilience.

BDX Expands U.S. Manufacturing With $19B Healthcare Investment

BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results

Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac artery disease. FRANKLIN LAKES, N.J.

BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results

Becton Dickinson Commits Massive $19 Billion To Expand Domestic Medical Manufacturing

Becton, Dickinson and Company (NYSE:BDX), a global medical technology firm and the largest domestic producer of critical medical consumables, on Tuesday announced a monumental partnership with the U.S. government.

Becton Dickinson Commits Massive $19 Billion To Expand Domestic Medical Manufacturing

BD Celebrates 65 Years of Manufacturing, Innovation and Community Partnership in Canaan

Generations of Connecticut employees have helped ensure the reliable supply of the BD® Syringe, an essential medical device clinicians rely on every day in patient care around the world CANAAN, Conn., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today marked 65 years of manufacturing in Canaan, Conn.

BD Celebrates 65 Years of Manufacturing, Innovation and Community Partnership in Canaan

BD Appoints Ferass Abuzaina as Worldwide President of Surgery

FRANKLIN LAKES, N.J., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Ferass Abuzaina has been named worldwide president of the Surgery business unit at BD, effective immediately.

BD Appoints Ferass Abuzaina as Worldwide President of Surgery

뉴스 순위 보기

Lightweight Charts™를 사용해 가격 차트를 구현했어요.